Concurrent administration of heparin and activated protein C in a patient with pulmonary embolism and severe sepsis with positive outcome

Results of the PROWESS trial suggested that heparin may reduce the efficacy of recombinant human activated protein C (rhAPC) and the XPRESS study also showed increased bleeding complications in patients receiving heparin with rhAPC. Although it has been shown that heparin prophylaxis may be used alo...

Descripción completa

Detalles Bibliográficos
Autores principales: Juneja, Deven, Mohan, S., Veturi, Vivek V., Gopal, Palepu B.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823100/
https://www.ncbi.nlm.nih.gov/pubmed/20040816
http://dx.doi.org/10.4103/0972-5229.58544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823100/
https://www.ncbi.nlm.nih.gov/pubmed/20040816
http://dx.doi.org/10.4103/0972-5229.58544

Ejemplares similares